Cargando…
Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver
Activation of the constitutive androstane receptor (CAR) may induce adaptive but also adverse effects in rodent liver, including the induction of drug-metabolizing enzymes, transient hepatocellular proliferation, and promotion of liver tumor growth. Human relevance of CAR-related adverse hepatic eff...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352639/ https://www.ncbi.nlm.nih.gov/pubmed/35881160 http://dx.doi.org/10.1007/s00204-022-03338-7 |
_version_ | 1784762692123230208 |
---|---|
author | Sprenger, Heike Rasinger, Josef Daniel Hammer, Helen Naboulsi, Wael Zabinsky, Elke Planatscher, Hannes Schwarz, Michael Poetz, Oliver Braeuning, Albert |
author_facet | Sprenger, Heike Rasinger, Josef Daniel Hammer, Helen Naboulsi, Wael Zabinsky, Elke Planatscher, Hannes Schwarz, Michael Poetz, Oliver Braeuning, Albert |
author_sort | Sprenger, Heike |
collection | PubMed |
description | Activation of the constitutive androstane receptor (CAR) may induce adaptive but also adverse effects in rodent liver, including the induction of drug-metabolizing enzymes, transient hepatocellular proliferation, and promotion of liver tumor growth. Human relevance of CAR-related adverse hepatic effects is controversially debated. Here, we used the chimeric FRG-KO mouse model with livers largely repopulated by human hepatocytes, in order to study human hepatocytes and their response to treatment with the model CAR activator phenobarbital (PB) in vivo. Mice received an intraperitoneal injection with 50 mg/kg body weight PB or saline, and were sacrificed after 72–144 h. Non-repopulated FRG-KO mice were used as additional control. Comprehensive proteomics datasets were generated by merging data obtained by targeted as well as non-targeted proteomics approaches. For the first time, a novel proteomics workflow was established to comparatively analyze the effects of PB on human and murine proteins within one sample. Analysis of merged proteome data sets and bioinformatics data mining revealed comparable responses in murine and human hepatocytes with respect to nuclear receptor activation and induction of xenobiotic metabolism. By contrast, activation of MYC, a key regulator of proliferation, was predicted only for mouse but not human hepatocytes. Analyses of 5-bromo-2′-deoxyuridine incorporation confirmed this finding. In summary, this study for the first time presents a comprehensive proteomic analysis of CAR-dependent effects in human and mouse hepatocytes from humanized FRG-KO mice. The data support the hypothesis that PB does induce adaptive metabolic responses, but not hepatocellular proliferation in human hepatocytes in vivo. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-022-03338-7. |
format | Online Article Text |
id | pubmed-9352639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-93526392022-08-06 Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver Sprenger, Heike Rasinger, Josef Daniel Hammer, Helen Naboulsi, Wael Zabinsky, Elke Planatscher, Hannes Schwarz, Michael Poetz, Oliver Braeuning, Albert Arch Toxicol Toxicogenomics and Omics Technologies Activation of the constitutive androstane receptor (CAR) may induce adaptive but also adverse effects in rodent liver, including the induction of drug-metabolizing enzymes, transient hepatocellular proliferation, and promotion of liver tumor growth. Human relevance of CAR-related adverse hepatic effects is controversially debated. Here, we used the chimeric FRG-KO mouse model with livers largely repopulated by human hepatocytes, in order to study human hepatocytes and their response to treatment with the model CAR activator phenobarbital (PB) in vivo. Mice received an intraperitoneal injection with 50 mg/kg body weight PB or saline, and were sacrificed after 72–144 h. Non-repopulated FRG-KO mice were used as additional control. Comprehensive proteomics datasets were generated by merging data obtained by targeted as well as non-targeted proteomics approaches. For the first time, a novel proteomics workflow was established to comparatively analyze the effects of PB on human and murine proteins within one sample. Analysis of merged proteome data sets and bioinformatics data mining revealed comparable responses in murine and human hepatocytes with respect to nuclear receptor activation and induction of xenobiotic metabolism. By contrast, activation of MYC, a key regulator of proliferation, was predicted only for mouse but not human hepatocytes. Analyses of 5-bromo-2′-deoxyuridine incorporation confirmed this finding. In summary, this study for the first time presents a comprehensive proteomic analysis of CAR-dependent effects in human and mouse hepatocytes from humanized FRG-KO mice. The data support the hypothesis that PB does induce adaptive metabolic responses, but not hepatocellular proliferation in human hepatocytes in vivo. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-022-03338-7. Springer Berlin Heidelberg 2022-07-26 2022 /pmc/articles/PMC9352639/ /pubmed/35881160 http://dx.doi.org/10.1007/s00204-022-03338-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Toxicogenomics and Omics Technologies Sprenger, Heike Rasinger, Josef Daniel Hammer, Helen Naboulsi, Wael Zabinsky, Elke Planatscher, Hannes Schwarz, Michael Poetz, Oliver Braeuning, Albert Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
title | Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
title_full | Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
title_fullStr | Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
title_full_unstemmed | Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
title_short | Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
title_sort | proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver |
topic | Toxicogenomics and Omics Technologies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352639/ https://www.ncbi.nlm.nih.gov/pubmed/35881160 http://dx.doi.org/10.1007/s00204-022-03338-7 |
work_keys_str_mv | AT sprengerheike proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT rasingerjosefdaniel proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT hammerhelen proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT naboulsiwael proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT zabinskyelke proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT planatscherhannes proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT schwarzmichael proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT poetzoliver proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver AT braeuningalbert proteomicanalysisofhepaticeffectsofphenobarbitalinmicewithhumanizedliver |